Glenohumeral OsteoArthritis Therapy Trial
Part of paid clinical trials in Buffalo, New York.
- Sponsor
- State University of New York at Buffalo
- Study ID
- NCT07744542
- Status
- Enrolling By Invitation
Conditions
- Glenohumeral Arthritis
- Shoulder Arthritis Osteoarthritis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Physical therapy — BEHAVIORAL12 weeks of designated physical therapy focused on improving shoulder strength and range of motion
- Home physical therapy — BEHAVIORAL12 weeks of home therapy program focused on improving shoulder strength and range of motion
Study Details
Arthritis of the shoulder glenohumeral joint is a growing problem in an aging population. Treatment options for glenohumeral arthritis can be grouped into three main categories: 1) shoulder replacement surgery, 2) injections (corticosteroid, hyaluronic acid and PRP) and physical therapy (PT). Surgery comes with risks and the potential for implant failure or revision over time. Therefore, it is typical for doctors to prescribe injections and/or PT before discussing surgery. Sometimes, insurance companies will require PT before considering a shoulder operation. It is unknown if PT is effective for improving function or pain with patients with glenohumeral arthritis. The aim of this study is to compare pain and functional outcomes after undergoing a 12 week PT program, at home PT exercises or delaying conservative treatment.
Key Dates
- First listed
- Aug 4, 2026
- Start date
- Jun 17, 2026
- Status verified
- Jun 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 125 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Physical Therapy12 weeks of designated physical therapy focused on improving shoulder strength and range of motion
- Experimental: Home Therapy12 weeks of home therapy program focused on improving shoulder strength and range of motion
- No Intervention: Control GroupSubjects continue with coping mechanisms for 12 week period, no intervention
Primary Outcome Measure
Visual analog scale (VAS) [ Time Frame: Time 0, 6 weeks, 12 weeks, 1 year ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UBMD Orthopaedics & Sports Medicine | Buffalo | New York | 14221-2108 | - |
Find similar trials in Buffalo, NY
Related Studies
- Corticosteroid Injection Versus Nerve BlockRecruiting · University of Minnesota · Minneapolis, Minnesota